June 25, 2012
Middleboro, MA – Brookfield Engineering Laboratories offers the TA-EP Eye Pencil Test Fixture for their CT3 Texture Analyzer. The Eye Pencil Test Fixture is designed to measure the hardness of eye pencils, lip liners and other similar cosmetic products. Brookfield offers a wide variety of test fixtures for the cosmetic and pharmaceutical industries including a [...]
FDA Approves New Blood Test to Improve Prostate Cancer Detection
June 25, 2012
BREA, CALIF. — Beckman Coulter, Inc., the leader in prostate cancer diagnostics, announces Premarket Approval (PMA) from the U.S. Food and Drug Administration (FDA) for the Prostate Health Index (phi), a simple, non-invasive blood test that is 2.5 times more specific in detecting prostate cancer1 than PSA (prostate-specific antigen) in patients with PSA values in [...]
RainDance Technologies Unveils Digital PCR Platform to European Market
June 25, 2012
LEXINGTON, Mass. AND NUREMBERG, Germany, – RainDance Technologies, Inc., the Digital Biology™ Company, today announced the introduction of its new RainDrop™ Digital PCR System to the European genetics research market. Attendees of the annual European Society of Human Genetics (ESHG) meeting in Nuremberg, Germany have the opportunity to see demonstrations of the system, which establishes [...]
SAW Instruments Places sam® X Biosensor with Full Spectrum Genetics
June 25, 2012
Bonn, Germany – SAW Instruments LLC has inked a deal with US firm Full Spectrum Genetics (FSG) to place a high-end sam® X biosensor in FSG’s San Francisco laboratory. Financial terms of the deal have not been disclosed. Within the agreement, FSG will have full access to the biosensor for its own internal research programs, [...]
June 25, 2012
HILDEN, Germany, and GERMANTOWN, Maryland, USA, - QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today unveiled an advanced initiative to enter the field of next-generation sequencing (NGS) that aims to establish these technologies as routine processes used in new areas such as clinical research and molecular diagnostics. QIAGEN is in the advanced stages of [...]
PerkinElmer Announces OneSource® Scientific IT Services to Drive Laboratory Productivity Growth
June 25, 2012
WALTHAM, Mass. -- PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today unveiled its OneSource® Scientific IT Services, a suite of informatics-based consulting, planning, and management offerings designed to help maximize the productivity of information technology in laboratory environments. The OneSource Scientific IT Services comprise Lab [...]
NextBio and Cancer Care Institute Form Strategic Partnership Focused on Clinical Use of Genomics
June 25, 2012
SANTA CLARA, Calif.-- NextBio and Cancer Care Institute (CCI) announced today a strategic partnership aimed at furthering the adoption of genomics in the clinic. The collaboration will facilitate use of the NextBio platform to interpret genomic molecular data for oncology patients and streamline the complete workflow for use of molecular data in a clinical setting. [...]
June 25, 2012
ST. LOUIS -- Certara™, a market-leading provider of software and scientific services to improve productivity and decision-making in clinical drug development, announced today that the University of Maryland School of Pharmacy’s Center for Translational Medicine (CTM) has been named as the latest Phoenix® Center of Excellence, expanding the program created by Pharsight (now Certara), and [...]
June 25, 2012
LEXINGTON, Mass. AND MUNICH, Germany,– RainDance Technologies, Inc., the Digital Biology™ Company, today announced that MLL Munich Leukemia Laboratory (MLL) has purchased the company's ThunderStorm™ System and consumables to process an initial 2,000 samples for use in the identification of prognostically relevant molecular mutations associated with Acute Myeloid Leukemia (AML) and other myeloid malignancies. Additionally, [...]
Affymetrix Completes Acquisition of eBioscience Holding Company, Inc.
June 25, 2012
SANTA CLARA, Calif.-- Affymetrix Inc., (NASDAQ:AFFX) today announced that the Company has completed its acquisition of eBioscience Holding Company, Inc., a privately-held company with an industry-leading position in flow cytometry and immunoassay reagents for immunology and oncology research and diagnostics. The acquisition enhances Affymetrix’s product portfolio and expands its addressable markets by more than $2.5 [...]
